United States Atopic Dermatitis Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

Atopic Dermatitis Market reached US$10.72 billion in 2024 and is expected to reach US$31.68 billion by 2033, growing at a CAGR of 13.7% during the forecast period 2025-2033, according to DataM Intelligence research.

Key Development:

United States: Recent Industry Developments

✅ In September 2025, the U.S. FDA approved Incyte's eczema cream, Opzelura, for pediatric patients aged 2 to 11. This approval extends the use of Opzelura, which became the first topical JAK inhibitor approved in 2021 for individuals 12 and older.

✅ In September 2025, Amgen and Kyowa Kirin announced top-line results from the Phase 3 ASCEND study of rocatinlimab in adults with moderate-to-severe atopic dermatitis. The study demonstrated the drug's ongoing therapeutic benefit at one year of treatment.

✅ In August 2025, Arcutis Biotherapeutics reported a 164% year-over-year increase in Q2 2025 net product revenue for ZORYVE® (roflumilast), driven by strong portfolio demand growth.

Japan: Recent Industry Developments

✅ In August 2025, Kyowa Kirin announced top-line results from the Phase 3 ASCEND study of rocatinlimab in adults with moderate-to-severe atopic dermatitis. The study showed the drug's ongoing therapeutic benefit at one year of treatment.

✅ In August 2025, Astria Therapeutics entered into a licensing agreement with Kaken Pharmaceutical to develop and commercialize Navenibart for hereditary angioedema in Japan.

✅ In August 2025, Corvus Pharmaceuticals provided a business update and reported second-quarter 2025 financial results, including data from the Phase 1 study of soquelitinib for atopic dermatitis.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/atopic-dermatitis-market?sb

Atopic Dermatitis is a chronic inflammatory skin condition characterized by itchy, red, and dry patches. Often associated with allergies or asthma, it affects quality of life and is managed through moisturizers, topical corticosteroids, immunomodulators, and lifestyle modifications to reduce flare-ups and irritation.

Recent Mergers and Acquisitions:

United States: Recent M&A and Strategic Partnerships

✅ In May 2025, Johnson & Johnson acquired Yellow Jersey Therapeutics for $1.25 billion, gaining rights to NM26, a bispecific antibody targeting IL-4Rα and IL-31, currently in Phase 2 trials for atopic dermatitis.

✅ In January 2025, Gilead Sciences secured exclusive global rights to LEO Pharma's preclinical oral STAT6 program, aiming to develop treatments for inflammatory diseases, including atopic dermatitis.

✅ In June 2025, Eli Lilly acquired Scorpion Therapeutics for $2.5 billion, obtaining the PI3Kα inhibitor program STX-478, a potential treatment for atopic dermatitis.

Japan: Recent M&A and Strategic Partnerships

✅ In December 2024, Ikena Oncology and Inmagene Biopharmaceuticals announced a merger, with a Phase 2b clinical trial of IMG-007 for atopic dermatitis expected to begin in early 2025.

✅ In September 2024, Organon agreed to acquire Roivant's dermatology unit, Dermavant, for up to $1.2 billion, gaining rights to Vtama, a treatment under FDA review for atopic dermatitis.

✅ In May 2024, Johnson & Johnson completed the acquisition of Proteologix for $850 million, enhancing its dermatology portfolio with bispecific antibodies targeting atopic dermatitis and asthma.

Key Players:

=> Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Eli Lilly and Company, Galderma Inc., LEO Pharma Inc., Incyte Corporation, Arcutis Biotherapeutics, Inc., Otsuka Pharmaceutical Co., Ltd, and others.

Growth Forecast Projected:

The Global Atopic Dermatitis Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Atopic Dermatitis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=atopic-dermatitis-market

Key Segments:

➥ By Treatment Type: Corticosteroids, Immunosuppressants, Biologics, Antihistamines, Others
➥ By Patient Type: Children, Adults
➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis for Atopic Dermatitis Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Atopic Dermatitis producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Atopic Dermatitis revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/atopic-dermatitis-market?sb

FAQ

What is the current size of the Atopic Dermatitis Market?

A: In 2024, the Atopic Dermatitis Market was valued at US$10.72 billion, reflecting its strong industry presence.

Q2: How large is the Atopic Dermatitis Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Atopic Dermatitis Market will grow to around US$31.68 billion , demonstrating significant expansion.

Q3: What is the growth rate of the Atopic Dermatitis Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 13.7% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.